Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.1M Buy
73,209
+1,034
+1% +$180K 1% 24
2026
Q1
$12.3M Buy
72,175
+12,261
+20% +$2.39M 0.98% 35
2025
Q4
$13.5M Sell
59,914
-857
-1% -$186K 1.02% 30
2025
Q3
$11.5M Buy
60,771
+115
+0.2% +$20.9K 0.85% 37
2025
Q2
$9.56M Sell
60,656
-3,167
-5% -$477K 0.74% 42
2025
Q1
$11.3M Buy
63,823
+6,684
+12% +$1.3M 0.96% 37
2024
Q4
$11.2M Sell
57,139
-16,730
-23% -$3.53M 0.93% 41
2024
Q3
$17.5M Buy
73,869
+426
+0.6% +$101K 1.46% 21
2024
Q2
$15.5M Sell
73,443
-66
-0.1% -$15K 1.38% 27
2024
Q1
$18.6M Buy
73,509
+4,924
+7% +$1.15M 1.71% 16
2023
Q4
$15.9M Buy
68,585
+58,839
+604% +$12.1M 1.78% 17
2023
Q3
$1.92M Buy
9,746
+6,515
+202% +$1.41M 1.61% 29
2023
Q2
$726K Buy
+3,231
New +$649K 0.59% 52

Other funds holding IQV

Nixon Peabody Trust's IQV Position: Q2 2026 in Review

Nixon Peabody Trust increased its IQVIA (IQV) stake by 1.4% in Q2 2026, buying an estimated $180K and bringing the position to 73,209 shares worth $14.1M. The position accounts for 1% of the portfolio, ranked #24.

Nixon Peabody Trust first reported a position in IQV in Q2 2023 and has held it in 13 quarters since. The position peaked at $18.6M in Q1 2024. 379 funds tracked by Wall St. Rank hold IQV as of Q2 2026.

  • Nixon Peabody Trust held 73,209 shares of IQVIA worth $14.1M as of Q2 2026.
  • Nixon Peabody Trust bought 1,034 IQVIA shares in Q2 2026, an estimated $180K.
  • IQVIA made up 1% of Nixon Peabody Trust's portfolio in Q2 2026, its #24 holding.
  • Nixon Peabody Trust first reported a position in IQVIA in Q2 2023 and has held it in 13 quarters since.
  • Nixon Peabody Trust's IQVIA position peaked at $18.6M in Q1 2024.
  • 379 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.